Ad
related to: Sanofi SA
Search results
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional...
Benzinga via Yahoo Finance· 1 year agoInnate Pharma SA (NASDAQ: IPHA) and Sanofi SA (NASDAQ: SNY) have expanded their collaboration, with...
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) elected to terminate its second amended and restated collaboration and...
Sanofi to let go of staff at vaccine plants in India as part of review
Reuters via Yahoo Finance· 1 year agoFrench drugmaker Sanofi SA is reviewing operations at two of its vaccine making facilities in India...
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
Benzinga via Yahoo Finance· 2 years agoInnovent Biologics Inc (OTC: IVBXF) and Sanofi SA (NASDAQ: SNY) have collaborated to develop and...
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Benzinga via Yahoo Finance· 1 year agoAfter Sanofi SA (NASDAQ: SNY) failed to secure a UNICEF contract, the company is weighing closing...
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said that uninsured diabetes patients in the U.S. will pay no more than $35...
FDA Approves Sanofi's Hemophilia A Therapy Offering Significant Bleed Protection
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Sanofi SA's (NASDAQ: SNY) Altuviiio, previously referred to as efanesoctocog alfa,...
Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech
Benzinga via Yahoo Finance· 2 years agoFrench pharma major Sanofi SA (NASDAQ: SNY) entered into a collaboration and licensing agreement...
Sanofi Offloads 17 Products To Neuraxpharm
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum. The...
